EcoDrugPlus

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSLBEG00000014878
Gene Symbol: TRPA1
3 Cross references
200 Possible Orthologues:

Transthyretin-Like

Ensembl ID : ENSLBEG00000000399
Gene Symbol: LOC109993409
3 Cross references
178 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSLBEG00000018122
Gene Symbol: TPH1
3 Cross references
207 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSLBEG00000002847
Gene Symbol: TUBA4A
3 Cross references
136 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSLBEG00000005944
Gene Symbol: LOC109984161
2 Cross references
144 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSLBEG00000010720
Gene Symbol: TUBB
3 Cross references
160 Possible Orthologues:

Tubulin Beta-1 Chain-Like

Ensembl ID : ENSLBEG00000016805
Gene Symbol: LOC110005921
2 Cross references
108 Possible Orthologues:

Tubulin Beta-2a Chain-Like

Ensembl ID : ENSLBEG00000018010
Gene Symbol: LOC109985130
3 Cross references
305 Possible Orthologues:

Tubulin Beta-6 Chain

Ensembl ID : ENSLBEG00000012606
Gene Symbol: LOC109986195
2 Cross references
184 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSLBEG00000027542
Gene Symbol: TP53
2 Cross references
232 Possible Orthologues:

Type-2 Angiotensin Ii Receptor-Like

Ensembl ID : ENSLBEG00000015021
Gene Symbol: LOC109981103
3 Cross references
185 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSLBEG00000000057
Gene Symbol: TYR
3 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).